基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物 细胞培养 细胞系 小鼠细胞系 GLU-ALA-ALA-GLY-ILE-GLY-ILE-LEU-THR-VAL
  • 156251-01-3

156251-01-3

L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine
156251-01-3
询价 20mg 起订
5mg 起订
10mg 起订
四川 更新日期:2024-08-12

成都彼样生物科技有限公司

VIP6年
联系人:鲜凤玲
电话:028-81700200拨打
手机:18108052721 拨打
邮箱:2850505130@qq.com

产品详情:

英文名称:
L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine
CAS号:
156251-01-3
品牌:
维克奇
保存条件:
-20℃,干燥、避光、密封
纯度规格:
HPLC≥98%
产品类别:
标准品

WKQ-0014730

英文名称:L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine

英文别名:L-Valine, N-[N-[N-[N-[N-[N-[N-[N-(N-L-α-glutamyl-L-alanyl)-L-alanyl]glycyl]-L-isoleucyl]glycyl]-L-isoleucyl]-L-leucyl]-L-threonyl]-;L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine;100: PN: WO2004000351 SEQID: 98 unclaimed sequence;107: PN: WO02069907 SEQID: 107 unclaimed sequence;123: PN: WO2011040978 PAGE: 49 unclaimed sequence;1281: PN: WO2006091734 PAGE: 71 claimed sequence;13: PN: JP2006236151 PAGE: 11 claimed sequence;13: PN: US20040191260 SEQID: 13 unclaimed sequence;13: PN: US20060083735 SEQID: 13 unclaimed sequence;13: PN: WO03047506 SEQID: 13 unclaimed sequence;13: PN: WO2006078059 SEQID: 13 claimed protein;14: PN: WO2020028719 SEQID: 22 claimed protein;16: PN: WO2020172472 SEQID: 160 claimed protein;173: PN: WO0178655 SEQID: 26 claimed sequence;18: PN: WO2010112962 SEQID: 25 unclaimed protein;191: PN: WO2011140284 SEQID: 228 claimed protein;1: PN: US6277956 SEQID: 1 unclaimed sequence;1: PN: WO0116320 SEQID: 1 unclaimed sequence;1: PN: WO2011140595 SEQID: 1 claimed protein;1: PN: WO2017193104 SEQID: 1 claimed protein;21: PN: WO2006120038 SEQID: 21 claimed sequence;21: PN: WO2008042814 SEQID: 20 claimed sequence;22: PN: WO2005037190 TABLE: 2 unclaimed sequence;23: PN: US6710172 SEQID: 24 unclaimed sequence;23: PN: WO2008120202 SEQID: 21 claimed sequence;24: PN: US6531451 SEQID: 24 unclaimed sequence;25: PN: WO2006082391 PAGE: 49 unclaimed sequence;26: PN: WO2011101332 SEQID: 28 claimed protein;273: PN: WO2022190007 SEQID: 273 claimed protein;27: PN: US7001999 SEQID: 27 unclaimed sequence;27: PN: WO0236146 SEQID: 27 claimed sequence;281: PN: WO2012044999 SEQID: 281 claimed sequence;285: PN: WO2019231920 SEQID: 344 claimed protein;2: PN: US20050095655 SEQID: 2 unclaimed sequence;2: PN: WO2012023033 SEQID: 2 claimed protein;2: PN: WO2015110397 SEQID: 2 claimed protein;30: PN: WO0021551 SEQID: 30 claimed sequence;31: PN: WO0050589 SEQID: 31 unclaimed sequence;32: PN: US6291430 SEQID: 68 unclaimed sequence;32: PN: WO0006598 SEQID: 33 unclaimed sequence;33: PN: US6245525 SEQID: 27 unclaimed sequence;34: PN: US20040033541 SEQID: 34 unclaimed sequence;34: PN: WO0020445 SEQID: 24 unclaimed sequence;34: PN: WO0129220 SEQID: 32 unclaimed sequence;34: PN: WO2008097817 SEQID: 34 unclaimed protein;37: PN: WO2005004907 SEQID: 37 unclaimed sequence;3: PN: EP2221060 SEQID: 3 claimed sequence;3: PN: US6326200 SEQID: 1 unclaimed sequence;3: PN: US7268219 SEQID: 3 unclaimed sequence;3: PN: US7723111 SEQID: 3 unclaimed protein;3: PN: WO02072850 SEQID: 3 unclaimed sequence;3: PN: WO2010089064 SEQID: 3 claimed sequence;40: PN: WO2010026165 SEQID: 40 unclaimed protein;41: PN: US20040023314 SEQID: 41 unclaimed sequence;41: PN: WO03100027 SEQID: 41 unclaimed sequence;43: PN: WO0013699 SEQID: 39 unclaimed sequence;4671: PN: WO2010037395 SEQID: 16634 claimed protein;46: PN: FR2842812 SEQID: 46 claimed sequence;47: PN: FR2842811 SEQID: 46 claimed sequence;480: PN: WO2022192524 SEQID: 490 claimed protein;4: PN: WO2011083296 SEQID: 2 unclaimed protein;4: PN: WO2015162204 SEQID: 4 claimed sequence;53: PN: WO0020581 SEQID: 68 unclaimed sequence;54: PN: WO0153833 SEQID: 39 unclaimed sequence;5: PN: WO2011050344 SEQID: 1 unclaimed protein;65: PN: WO0078806 SEQID: 65 unclaimed sequence;66: PN: WO0032785 SEQID: 32 unclaimed sequence;67: PN: US6716809 SEQID: 68 unclaimed sequence;68: PN: WO2004084940 SEQID: 68 unclaimed sequence;69: PN: WO2010143010 SEQID: 69 unclaimed sequence;71: PN: US20220233662 SEQID: 71 claimed protein;72: PN: US20090036653 SEQID: 73 unclaimed protein;75: PN: WO2004085635 SEQID: 78 unclaimed sequence;76: PN: WO2004035085 SEQID: 72 unclaimed sequence;78: PN: WO2012044999 SEQID: 78 unclaimed sequence;87: PN: WO2009051555 SEQID: 92 claimed protein;92: PN: WO2006138562 SEQID: 91 claimed protein;9: PN: WO2005042737 SEQID: 9 unclaimed protein;9: PN: WO2011140255 SEQID: 9 unclaimed protein;PN: WO9953061 SEQID: 27 unclaimed sequence;immunoglobulin, anti-(human MART-1/HLA-A2) (synthetic clone CLA12 L-chain);

分子式:C42H74N10O14

分子量:943.10

CAS号:156251-01-3

纯度:HPLC≥98%

沸点:1358.4±65.0 °C | Condition: Press: 760 Torr

密度:1.223±0.06 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr

酸系度数:3.32±0.10 | Condition: Most Acidic Temp: 25 °C

储存条件:-20℃,干燥、避光、密封

规格:5mg10mg20mg50mg100mg500mg1g2g等应客户需求包装

供应单位:四川省维克奇生物科技有限公司

供应电话:028-81700200/4008005713

四川省维克奇生物科技有限公司生产中药类标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。公司推出丹参系列、龙胆系列、虫草系列等,敬请关注!    新批次有现货,欢迎咨询。


156251-01-3;

公司简介

  成都彼样生物科技有限公司是四川省成都市一家专业从事天然药物纯化分离,集生产研发/销售于一体的公司。公司名下有四家公司“成都标样生物科技有限公司,成都超九八生物科技有限公司,四川省维克奇生物科技有限公司”。   2014年我公司与中国科学院成都生物研究所共建联合实验室,主打中药对照品/标准品/天然植物有效单体,化学合成,抗生素三大板块。实验室拥有一批精密的分离纯化系统和检测设备;拥有一批技术精湛的研究队伍;拥有一套完整的质量管理体系;   公司可承接以下业务:   1、指定化合物克级---公斤级定制业务;   2、指定药材全系列的分离纯化业务;   3、新化合物的分离纯化及结构鉴定业务;   4、指

成立日期 (8年)
注册资本 100000
员工人数 10-50人
年营业额 ¥ 100万-300万
经营模式 试剂
主营行业 化学试剂,高纯试剂

L-α-Glutamyl-L-alanyl-L-alanylglycyl-L-isoleucylglycyl-L-isoleucyl-L-leucyl-L-threonyl-L-valine相关厂家报价

内容声明
拨打电话 立即询价